Results 271 to 280 of about 9,546,669 (393)

REDUCTION BY COMBINATION PROPHYLACTIC THERAPY WITH CMV HYPERIMMUNE GLOBULIN AND ACYCLOVIR OF THE RISK OF PRIMARY CMV DISEASE IN RENAL TRANSPLANT RECIPIENTS

, 1993
DAVID L. NICOL, Allan S. MacDonald, P Belitsky, Spencer Lee, Allan D. Cohen, H Bitter-Suermann, JOSEPH LOWEN, ALICE WHALEN   +7 more
openalex   +1 more source

Antiretroviral combination therapy and HIV infection [PDF]

, 1998
J. McMenamin, G. Allardice, D. Goldberg, T. Parpira, G. Raab, R. Thiebaut, Frantz Thiessard, L. D. Merchadou, C. Marimoutou, F. Dabis   +9 more
openalex   +1 more source

Understanding and measuring mechanical signals in the tumor stroma

FEBS Open Bio, EarlyView.
This review discusses cancer‐associated fibroblast subtypes and their functions, particularly in relation to extracellular matrix production, as well as the development of 3D models to study tumor stroma mechanics in vitro. Several quantitative techniques to measure tissue mechanical properties are also described, to emphasize the diagnostic and ...
Fàtima de la Jara Ortiz, Chiara Cimmino, Maurizio Ventre, Alessandra Cambi   +3 more
wiley   +1 more source

Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis [PDF]

, 1995
Peter Tugwell, Theodore Pincus, David E. Yocum, Michael Ashley Stein, Oscar Gluck, G Kraag, R J McKendry, John Tesser, P. D. Baker, George A. Wells   +9 more
openalex   +1 more source

Beyond digital twins: the role of foundation models in enhancing the interpretability of multiomics modalities in precision medicine

FEBS Open Bio, EarlyView.
This review highlights how foundation models enhance predictive healthcare by integrating advanced digital twin modeling with multiomics and biomedical data. This approach supports disease management, risk assessment, and personalized medicine, with the goal of optimizing health outcomes through adaptive, interpretable digital simulations, accessible ...
Sakhaa Alsaedi, Xin Gao, Takashi Gojobori   +2 more
wiley   +1 more source

Development of CD73 Inhibitors in Tumor Immunotherapy and Opportunities in Imaging and Combination Therapy. [PDF]

J Med Chem
Bi C, Patel JS, Liang SH.
europepmc   +1 more source

Bioengineering facets of the tumor microenvironment in 3D tumor models: insights into cellular, biophysical and biochemical interactions

FEBS Open Bio, EarlyView.
The tumor microenvironment is a dynamic, multifaceted complex system of interdependent cellular, biochemical, and biophysical components. Three‐dimensional in vitro models of the tumor microenvironment enable a better understanding of these interactions and their impact on cancer progression and therapeutic resistance.
Salma T. Rafik, Deniz Bakkalci, Alexander J. MacRobert, Umber Cheema   +3 more
wiley   +1 more source

Evaluation of Additive Neuroprotective Effect of Combination Therapy for Parkinson's Disease Using In Vitro Models. [PDF]

Antioxidants (Basel)
Shtilbans A, Esneault E, Simon F, Mazzulli JR, Quiriconi DJ, Rom D, Reintsch WE, Krahn AI, Durcan TM.   +8 more
europepmc   +1 more source

EVIDENCE THAT COMBINATION THERAPY USING COBRA VENOM FACTOR, SPLENECTOMY, AND DEOXYSPERGUALIN IS EFFECTIVE IN GUINEA PIG TO RAT CARDIAC XENOTRANSPLANTATION1

, 1994
NULL AUTHOR_ID
openalex   +1 more source

Comparative single‐cell transcriptomic profiling of patient‐derived renal carcinoma cells in cellular and animal models of kidney cancer

FEBS Open Bio, EarlyView.
We generated and characterized clear cell renal cell carcinoma models using the patient‐derived RCC243 cell line—including cell culture, orthotopic, and metastatic tumors—via single‐cell RNA‐sequencing for comparisons between models and patient tumor datasets.
Richard Huang, Lynn Kee, Alexander Gont, Jalna Meens, Fraser G. Ferens, Meredith S. Irwin, Laurie Ailles, Scott A. Yuzwa, Claire M. Robinson, Michael Ohh   +9 more
wiley   +1 more source